ImmunoGen (IMGN) Presents At Cowen and Company 37th Annual Health Care Conference

3/8/17

By Seeking Alpha

The following slide deck was published by ImmunoGen, Inc. in conjunction with this event.

110

Nasdaq: IMGN Forward-Looking Statements This presentation includes forward-looking statements based on management's current expectations. These statements include, but are not limited to, ImmunoGen's expectations related to: the occurrence, timing and outcome of potential pre-clinical, clinical and regulatory events related to the Company's and its collaboration partners' product programs; the presentation of preclinical and clinical data on the Companys and its collaboration partners product candidates; and the financial guidance provided. For these statements, ImmunoGen claims the protection of the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. Various factors could cause ImmunoGen's actual results to differ materially from those discussed or implied in the forward-looking statements, and you are cautioned not to place undue reliance on these forward-looking statements, which are current only as of the date of these slides. Factors that could cause future results to differ materially from such expectations include, but are not limited to: the timing and outcome of ImmunoGen's and its collaboration partners' research and clinical development processes; the difficulties inherent in the development of novel pharmaceuticals, including uncertainties as to the timing, expense and results of preclinical studies, clinical trials and regulatory processes; ImmunoGen's ability to financially support its product programs; the Companys dependence on its collaborative partners; industry merger and acquisition activity; and other factors more fully described in ImmunoGen's Annual Report on Form 10-K for the fiscal year ended June 30, 2016 and other reports filed with the Securities and Exchange Commission. 2

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.

Sponsored -
Agency/Corporate Program

MG+M Elevates Attorneys Stephanie Chesney and Shannon O’Neil Partner

MG+M The Law Firm (MG+M) is pleased to announce that it has elevated attorneys Stephanie M. Chesney

Burns & Levinson Adds Leading Plaintiff Employment Litigator Beth Myers as a Partner

Burns & Levinson announced today that well-known plaintiff employment litigator Beth R. Myers has joined the firm

BayCoast Bank Names Nicole Almeida as SVP, Chief Diversity Officer

BayCoast Bank is delighted to announce Nicole Almeida as Senior Vice President, Chief Diversity Officer (CDO)

BayCoast Bank Appoints Robert Bergdoll as First VP Marketing Director

BayCoast Bank is pleased to announce Robert Bergdoll of Attleboro, Massachusetts, as First Vice President Marketing Director

TRUSTED BY
THESE PARTNERS: